Comparison of Efficacy and Safety of Bleb Needle Revision With and Without 5-Fluorouracil for Failing Trabeculectomy Bleb
- PMID: 30839411
- DOI: 10.1097/IJG.0000000000001226
Comparison of Efficacy and Safety of Bleb Needle Revision With and Without 5-Fluorouracil for Failing Trabeculectomy Bleb
Abstract
PRéCIS:: Bleb needle revision with and without 5-FU showed similar success rates over the course of a long-term follow-up. A greater total number of needle revisions was identified as a risk factor for procedural failure.
Purpose: The purpose of the study was to investigate the efficacy and safety of bleb needle revision with adjunctive 5-fluorouracil (5-FU) subconjunctival injection in large-scaled patients with failing trabeculectomy bleb.
Materials and methods: A retrospective chart review was performed on a total of 113 eyes of 106 subjects who had undergone trabeculectomy followed by needle revision and been followed up for at least 6 months. The subjects were divided into 2 groups according to whether they had also undergone concurrent adjunctive 5-FU subconjunctival injection. Two definitions of failure were derived irrespective of IOP-lowering medication use and were assessed at each follow-up visit: (1) IOP>21 mm Hg or >85% of preoperative IOP or reoperation for glaucoma, (2) IOP>18 mm Hg or >80% of preoperative IOP or reoperation for glaucoma.
Results: A total of 78 eyes of 73 subjects underwent the simple needle revision procedure and 35 eyes of 33 subjects underwent needle revision with subconjunctival 5-FU injection. There was no significant adverse event for either group and no significant IOP difference in any of the observational periods between them (P=0.867). There was also no statistically significant difference in the total number of IOP-lowering medications between the groups (P=0.199). The success rate at 24 months after the first needle revision was 45.6% (95% CI: 33.7, 56.7) in simple revision group and 44.6% (95% CI: 27.7, 60.2) in 5-FU needle revision group by failure 1, 36.3% (95% CI: 25.4, 47.2) and 32.9% (95% CI: 18.0, 48.6) by failure 2, respectively. A greater total number of needle revisions was the significant risk factors for needle revision failure (HR=2.25 and P=0.001 according to failure 2).
Conclusions: Bleb needle revision with 5-FU subconjunctival injection is a safe procedure for failing trabeculectomy bleb. Bleb needle revision with and without 5-FU were equally likely to succeed.
Similar articles
-
The role of needle revision and 5-fluorouracil application over the filtration site in the management of bleb failure after trabeculectomy: a prospective study.Doc Ophthalmol. 2003 Mar;106(2):189-93. doi: 10.1023/a:1022550125261. Doc Ophthalmol. 2003. PMID: 12678284
-
Needle revision of failed filtering blebs using 5-Fluorouracil and a combined ab-externo and ab-interno approach.J Glaucoma. 2005 Feb;14(1):47-51. doi: 10.1097/00061198-200502000-00009. J Glaucoma. 2005. PMID: 15650604
-
Outcomes: Trabeculectomy Bleb Needle Revision With 5-Fluorouracil.J Glaucoma. 2016 Mar;25(3):317-23. doi: 10.1097/IJG.0000000000000235. J Glaucoma. 2016. PMID: 25719228
-
Trabeculectomy with intraoperative sponge 5-fluorouracil in Afro-Caribbeans.Br J Ophthalmol. 1997 Jul;81(7):555-8. doi: 10.1136/bjo.81.7.555. Br J Ophthalmol. 1997. PMID: 9290368 Free PMC article. Review.
-
Bleb resuscitation of failing, leaking and dysfunctional blebs: A review.Indian J Ophthalmol. 2025 Mar 1;73(Suppl 2):S197-S206. doi: 10.4103/IJO.IJO_1233_24. Epub 2025 Feb 21. Indian J Ophthalmol. 2025. PMID: 39982080 Free PMC article. Review.
Cited by
-
Three-year outcomes of surgical bleb revision with mitomycin C for early scarring bleb after trabeculectomy.Jpn J Ophthalmol. 2025 Jan;69(1):101-109. doi: 10.1007/s10384-024-01142-7. Epub 2024 Nov 21. Jpn J Ophthalmol. 2025. PMID: 39570505 Free PMC article.
-
Efficacy and safety of 5-fluorouracil in infrared monitor guided bleb revision.BMC Ophthalmol. 2021 Feb 8;21(1):75. doi: 10.1186/s12886-021-01843-4. BMC Ophthalmol. 2021. PMID: 33557751 Free PMC article.
-
Safety and Efficacy of the Rho-Kinase Inhibitor (Ripasudil) in Bleb Needling after Trabeculectomy: A Prospective Multicenter Study.J Clin Med. 2023 Dec 22;13(1):75. doi: 10.3390/jcm13010075. J Clin Med. 2023. PMID: 38202082 Free PMC article.
-
Safety and Efficacy of Bleb Needling with Antimetabolite after Trabeculectomy Failure in Glaucoma Patients: A Systemic Review and Meta-Analysis.J Ophthalmol. 2020 Nov 30;2020:4310258. doi: 10.1155/2020/4310258. eCollection 2020. J Ophthalmol. 2020. PMID: 33335782 Free PMC article.
-
A multicenter phase II study on the safety of rho-kinase inhibitor (ripasudil) with needling for the patients after trabeculectomy.Contemp Clin Trials Commun. 2023 Jun 4;33:101160. doi: 10.1016/j.conctc.2023.101160. eCollection 2023 Jun. Contemp Clin Trials Commun. 2023. PMID: 37333977 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical